Cite
HARVARD Citation
Vijayakumar, A. et al. (2022). Combinations of an acetyl CoA carboxylase inhibitor with hepatic lipid modulating agents do not augment antifibrotic efficacy in preclinical models of NASH and fibrosis. Hepatology communications. 6 (9), pp. 2298-2309. [Online].